These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 33309815)

  • 1. Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy.
    Cruz-Teran C; Tiruthani K; McSweeney M; Ma A; Pickles R; Lai SK
    Adv Drug Deliv Rev; 2021 Feb; 169():100-117. PubMed ID: 33309815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Learning from past failures: Challenges with monoclonal antibody therapies for COVID-19.
    Lai SK; McSweeney MD; Pickles RJ
    J Control Release; 2021 Jan; 329():87-95. PubMed ID: 33276017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
    Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
    Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide and peptide-based inhibitors of SARS-CoV-2 entry.
    Schütz D; Ruiz-Blanco YB; Münch J; Kirchhoff F; Sanchez-Garcia E; Müller JA
    Adv Drug Deliv Rev; 2020 Dec; 167():47-65. PubMed ID: 33189768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, pharmaceutical point of view.
    Najmeddin A; Bahrololoumi Shapourabadi M; Behdani M; Dorkoosh F
    Biochim Biophys Acta Gen Subj; 2021 Nov; 1865(11):129974. PubMed ID: 34343644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe acute respiratory syndrome-coronavirus-2: Current advances in therapeutic targets and drug development.
    Suganya S; Divya S; Parani M
    Rev Med Virol; 2021 May; 31(3):e2174. PubMed ID: 32965078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments.
    Canedo-Marroquín G; Saavedra F; Andrade CA; Berrios RV; Rodríguez-Guilarte L; Opazo MC; Riedel CA; Kalergis AM
    Front Immunol; 2020; 11():569760. PubMed ID: 33362758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model.
    Haagmans BL; Noack D; Okba NMA; Li W; Wang C; Bestebroer T; de Vries R; Herfst S; de Meulder D; Verveer E; van Run P; Lamers MM; Rijnders B; Rokx C; van Kuppeveld F; Grosveld F; Drabek D; Geurts van Kessel C; Koopmans M; Bosch BJ; Kuiken T; Rockx B
    J Infect Dis; 2021 Jun; 223(12):2020-2028. PubMed ID: 34043806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tackling COVID-19 with neutralizing monoclonal antibodies.
    Corti D; Purcell LA; Snell G; Veesler D
    Cell; 2021 Jun; 184(12):3086-3108. PubMed ID: 34087172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic or relapsing COVID-19 in immunodeficiency.
    Brown LK; Moran E; Goodman A; Baxendale H; Bermingham W; Buckland M; AbdulKhaliq I; Jarvis H; Hunter M; Karanam S; Patel A; Jenkins M; Robbins A; Khan S; Simpson T; Jolles S; Underwood J; Savic S; Richter A; Shields A; Brown M; Lowe DM
    J Allergy Clin Immunol; 2022 Feb; 149(2):557-561.e1. PubMed ID: 34780850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
    Weisblum Y; Schmidt F; Zhang F; DaSilva J; Poston D; Lorenzi JC; Muecksch F; Rutkowska M; Hoffmann HH; Michailidis E; Gaebler C; Agudelo M; Cho A; Wang Z; Gazumyan A; Cipolla M; Luchsinger L; Hillyer CD; Caskey M; Robbiani DF; Rice CM; Nussenzweig MC; Hatziioannou T; Bieniasz PD
    Elife; 2020 Oct; 9():. PubMed ID: 33112236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Audio Interview: Monoclonal Antibodies and Vaccine Boosts.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Jul; 385(3):e18. PubMed ID: 34260844
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline.
    Tuccori M; Ferraro S; Convertino I; Cappello E; Valdiserra G; Blandizzi C; Maggi F; Focosi D
    MAbs; 2020; 12(1):1854149. PubMed ID: 33319649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Perspectives of SARS-CoV-2: Pathology, Immune Evasion, and Therapeutic Interventions.
    Shah M; Woo HG
    Mol Cells; 2021 Jun; 44(6):408-421. PubMed ID: 34059561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Drug Development.
    Kim S
    J Microbiol Biotechnol; 2022 Jan; 32(1):1-5. PubMed ID: 34866128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody.
    Maruyama S; Wada D; Kanayama S; Shimazu H; Miyano Y; Inoue A; Kashihara M; Okuda K; Saito F; Nakamori Y; Ishii K; Kuwagata Y
    BMC Infect Dis; 2024 Jul; 24(1):715. PubMed ID: 39039440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive immunization and its rebirth in the era of the COVID-19 pandemic.
    Pavia CS; Wormser GP
    Int J Antimicrob Agents; 2021 Mar; 57(3):106275. PubMed ID: 33400975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspective on the Role of Antibodies and Potential Therapeutic Drugs to Combat COVID-19.
    Tandon S; Aggarwal A; Jain S; Shukla S; Chaudhary S
    Protein J; 2020 Dec; 39(6):631-643. PubMed ID: 33034824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19).
    Andrew M; Jayaraman G
    Carbohydr Res; 2021 Jul; 505():108326. PubMed ID: 34015720
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.